Management tracks

Rare diseases company Swedish Orphan Biovitrum AB (SSE:SOBI) said CEO Geoffrey McDonough will leave the company on July 1. The company is searching for a replacement. The company also named Armin Reininger SVP and head of global medical and scientific affairs. He was head of medical affairs EMEA for hemophilia and head of medical affairs global for hematology at Baxalta Inc., which Shire plc (LSE:SHP; NASDAQ:SHPG) acquired.

Antifungal company Amplyx Pharmaceuticals Inc. (San Diego, Calif.) promoted Ciara Kennedy to president and CEO from COO and promoted Karen Shaw to CSO from VP of biology...